Published in Hepatitis Weekly, April 1st, 1996
Researcher John P. Hanley and colleagues from the University of Scotland reported ALT normalization in only 28 percent of hemophiliacs with hepatitis C virus (HCV) infection treated with interferon after six months of therapy. The researchers also reported that sustained responses to interferon therapy were uncommon.
Virtually all hemophiliacs who received clotting factor concentrates before the introduction of effective viral-inactivation techniques were infected with HCV.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.